Related Experiment Video
Updated: May 13, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Cardioprotection in cardiovascular surgery
Sharif A Sabe1, Dwight D Harris1, Mark Broadwin1
1Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Rhode Island Hospital, Alpert Medical School of Brown University, 2 Dudley Street, MOC 360, Providence, RI, 02905, USA.
Insights
Improved cardioprotective strategies are crucial for complex cardiac surgeries. This review explores methods to reduce heart injury during cardiopulmonary bypass and enhance patient recovery.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardioprotection
Background:
- Cardiopulmonary bypass (CPB) necessitates strategies to prevent myocardial ischemic injury.
- Complex cardiac surgeries require enhanced cardioprotective measures for better patient outcomes.
- Advances in surgical techniques and support systems increase the need for optimized cardioprotection.
Purpose of the Study:
- To review fundamental cardioprotection principles in cardiac surgery.
- To discuss current and novel strategies for optimizing cardioprotection.
- To highlight translational research, including cell and gene therapy, for myocardial protection.
Main Methods:
- Review of existing literature on cardioprotection mechanisms and strategies.
- Discussion of refinements in CPB, cardioplegia, and anesthetic agents.
- Exploration of ischemic conditioning, mechanical circulatory support, and cell/gene therapies.
Main Results:
- Cardiac injury during CPB involves ischemia and reperfusion.
- Optimizing cardioprotection involves refining CPB, cardioplegia, and pharmacological interventions.
- Emerging cell-based and gene therapies show promise for myocardial protection.
Conclusions:
- Effective cardioprotection is vital for managing complex cardiac surgical patients.
- A multifaceted approach combining established and novel strategies is essential.
- Future research in cell and gene therapy may significantly improve outcomes in cardiac surgery.
Abstract:
Since the invention of cardiopulmonary bypass, cardioprotective strategies have been investigated to mitigate ischemic injury to the heart during aortic cross-clamping and reperfusion injury with cross-clamp release. With advances in cardiac surgical and percutaneous techniques and post-operative management strategies including mechanical circulatory support, cardiac surgeons are able to operate on more complex patients. Therefore, there is a growing need for improved cardioprotective strategies to optimize outcomes in these patients. This review provides an overview of the basic principles of cardioprotection in the setting of cardiac surgery, including mechanisms of cardiac injury in the context of cardiopulmonary bypass, followed by a discussion of the specific approaches to optimizing cardioprotection in cardiac surgery, including refinements in cardiopulmonary bypass and cardioplegia, ischemic conditioning, use of specific anesthetic and pharmaceutical agents, and novel mechanical circulatory support technologies. Finally, translational strategies that investigate cardioprotection in the setting of cardiac surgery will be reviewed, with a focus on promising research in the areas of cell-based and gene therapy. Advances in this area will help cardiologists and cardiac surgeons mitigate myocardial ischemic injury, improve functional post-operative recovery, and optimize clinical outcomes in patients undergoing cardiac surgery.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management

